Skip to search formSkip to main contentSkip to account menu

velnacrine maleate

Known as: (+-)-9-Amino-1,2,3,4-tetrahydro-1-acridinol maleate (1:1) (salt), 1,2,3,4-tetrahydro-9-aminoacridin-1-ol maleate 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (2)

HP 029P83 6029A

Broader (1)

velnacrine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Redox thiol status plays a central role in the mobilization and metabolism of nitric oxide in human red blood cells
2007
2007
Effects of velnacrine maleate in the leukocyte-endothelial cell interactions in rat cremaster microcirculatory network.
The expression of acetylcholinesterase in proinflammatory cells has supported the hypothesis that this protein plays a role in… 
2004
2004
Amperometric measurements of nitric oxide in erythrocytes.
Highly Cited
1995
Highly Cited
1995
Caregiver time use: An outcome measure in clinical trial research on Alzheimer's disease
1995
1995
Effectiveness and Safety of Velnacrine for the Treatment of Alzheimer's Disease: A Double-blind, Placebo-Controlled Study
Background: Alzheimer's disease is characterized by cognitive and behavioral disturbances that are mediated in part by… 
1995
1995
Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group.
BACKGROUND Alzheimer's disease is characterized by cognitive and behavioral disturbances that are mediated in part by cholinergic… 
1995
1995
Velnacrine maleate improves delayed matching performance by aged monkeys
Velnacrine maleate is a novel, orally active acetylcholinesterase inhibitor of the acridine class with a longer duration of… 
1993
1993
Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
This study describes the disposition of [14C]velnacrine maleate in rats, dogs, and humans, and the isolation and identification… 
1991
1991
Evaluation of HP 029 (Velnacrine Maleate) in Alzheimer's Disease a
HP 029 (1,2,3,4-tetrahydro-9-aminoacridin-1-ol-maleate) is a cholinesterase inhibitor and one of a series of compounds… 
1989
1989
Single Dose Safety, Tolerance, and Pharmacokinetics of HP 029 in Healthy Young Men: A Potential Alzheimer Agent
1,2,3,4‐tetrahydro‐9‐aminoacridin‐1‐ol maleate (HP 029) is a new cholinergic compound that has been shown to enhance memory in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)